Company intelligence / Profile preview
Bioxyne
Sydney, New South Wales, Australiabioxyne.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Bioxyne develops, manufactures, markets, and distributes a broad portfolio of consumer health products—including patented probiotics, functional foods/beverages/shakes/supplements—and has expanded into novel medicines such as medicinal cannabis and psychedelics through its subsidiary Breathe Life Sciences. The company holds Australia’s first GMP license to manufacture MDMA/psilocybin for research/commercialization targeting mental health disorders. It also operates telemedicine services via BLS Clinics. Its probiotic supplement "Progastrim" targets gut immunity/wellness; the company historically developed HI164OV immunotherapy for COPD through Phase IIb trials but current focus has shifted toward psychotropic medicine innovation.
- Therapeutic areas
- PulmonologyPsychiatryGastroenterologyMetabolic Disorders
- Modalities
- Small molecule (e.g., cannabinoids, MDMA)Live biotherapeutic product therapy (probiotics)Plant-based productsFunctional foods and nutraceuticalsPsychedelic therapy (psilocybin)Medicinal cannabis products
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Cy Biopharma AG of Switzerland—commercial supply/collaboration agreement signed May 2024
Beyond the preview
Go deeper on Bioxyne.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioxyne.